Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients

Authors


Address correspondence and reprint requests to F. R. Wiedemann, Neurobiochemisches Labor, Klinik für Neurologie, Universität Magdeburg, Leipziger Str. 44, 39120 Magdeburg, Germany. E-mail: falk.wiedemann@medizin.uni-magdeburg.de

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by selective motor neuron death. In order to address the question of a putative role of mitochondrial dysfunction in the pathogenesis of ALS, we studied the mitochondrial DNA (mtDNA) and mitochondrial respiratory chain enzyme activities in spinal cords of ALS patients and in control subjects without neuropathologic abnormalities. Using a ‘double PCR and digestion’ technique to estimate the levels of randomly distributed point mutations in two small regions of the mtDNA, we found significantly higher levels of mutant mtDNA in the spinal cord of ALS patients compared to controls. No large-scale rearrangements were found, but the amount of mtDNA, measured by Southern blot, was significantly lower in the ALS samples. This reduction correlated well with a decrease of citrate synthase (CS) activity, a mitochondrial marker, as were the activities of respiratory chain complexes I + III, II + III, and IV, suggesting a loss of mitochondria in ALS spinal cords.

Ancillary